Pyridinylimidazole Compound SB 203580 Inhibits the Activity but Not the Activation of p38 Mitogen-Activated Protein Kinase
- 1 October 1999
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 263 (3) , 825-831
- https://doi.org/10.1006/bbrc.1999.1454
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- SB 203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin‐1Published by Wiley ,2000
- TL1, a Novel Tumor Necrosis Factor-like Cytokine, Induces Apoptosis in Endothelial Cells: INVOLVEMENT OF ACTIVATION OF STRESS PROTEIN KINASES (STRESS-ACTIVATED PROTEIN KINASE AND p38 MITOGEN-ACTIVATED PROTEIN KINASE) AND CASPASE-3-LIKE PROTEASEPublished by Elsevier ,1999
- Novel Homologues of CSBP/p38 MAP Kinase: Activation, Substrate Specificity and Sensitivity to Inhibition by Pyridinyl ImidazolesBiochemical and Biophysical Research Communications, 1997
- Mammalian Mitogen-activated Protein Kinase Pathways Are Regulated through Formation of Specific Kinase-Activator ComplexesJournal of Biological Chemistry, 1996
- Cloning and Characterization of MEK6, a Novel Member of the Mitogen-activated Protein Kinase Kinase CascadePublished by Elsevier ,1996
- Transcriptional regulation by MAP kinasesMolecular Reproduction and Development, 1995
- PD 098059 Is a Specific Inhibitor of the Activation of Mitogen-activated Protein Kinase Kinase in Vitro and in VivoJournal of Biological Chemistry, 1995
- Pro-inflammatory Cytokines and Environmental Stress Cause p38 Mitogen-activated Protein Kinase Activation by Dual Phosphorylation on Tyrosine and ThreonineJournal of Biological Chemistry, 1995
- Interleukin-1 beta-modulated gene expression in immortalized human chondrocytes.Journal of Clinical Investigation, 1994
- A MAP Kinase Targeted by Endotoxin and Hyperosmolarity in Mammalian CellsScience, 1994